These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33763720)

  • 1. Mediterranean diet consumption affects the endocannabinoid system in overweight and obese subjects: possible links with gut microbiome, insulin resistance and inflammation.
    Tagliamonte S; Laiola M; Ferracane R; Vitale M; Gallo MA; Meslier V; Pons N; Ercolini D; Vitaglione P
    Eur J Nutr; 2021 Oct; 60(7):3703-3716. PubMed ID: 33763720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake.
    Meslier V; Laiola M; Roager HM; De Filippis F; Roume H; Quinquis B; Giacco R; Mennella I; Ferracane R; Pons N; Pasolli E; Rivellese A; Dragsted LO; Vitaglione P; Ehrlich SD; Ercolini D
    Gut; 2020 Jul; 69(7):1258-1268. PubMed ID: 32075887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndrome.
    Soldevila-Domenech N; Pastor A; Sala-Vila A; Lázaro I; Boronat A; Muñoz D; Castañer O; Fagundo B; Corella D; Fernández-Aranda F; Martínez-González MÁ; Salas-Salvadó J; Fitó M; de la Torre R
    Front Nutr; 2022; 9():1076677. PubMed ID: 36532543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoids, endocannabinoid-like molecules and their precursors in human small intestinal lumen and plasma: does diet affect them?
    Tagliamonte S; Gill CIR; Pourshahidi LK; Slevin MM; Price RK; Ferracane R; Lawther R; O'Connor G; Vitaglione P
    Eur J Nutr; 2021 Jun; 60(4):2203-2215. PubMed ID: 33104865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism.
    Fanelli F; Mezzullo M; Repaci A; Belluomo I; Ibarra Gasparini D; Di Dalmazi G; Mastroroberto M; Vicennati V; Gambineri A; Morselli-Labate AM; Pasquali R; Pagotto U
    Mol Metab; 2018 Aug; 14():82-94. PubMed ID: 29935920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention.
    Soldevila-Domenech N; Fagundo B; Cuenca-Royo A; Forcano L; Gomis-González M; Boronat A; Pastor A; Castañer O; Zomeño MD; Goday A; Dierssen M; Baghizadeh Hosseini K; Ros E; Corella D; Martínez-González MÁ; Salas-Salvadó J; Fernández-Aranda F; Fitó M; de la Torre R
    Nutr J; 2024 Jun; 23(1):61. PubMed ID: 38862960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology.
    Dao MC; Everard A; Aron-Wisnewsky J; Sokolovska N; Prifti E; Verger EO; Kayser BD; Levenez F; Chilloux J; Hoyles L; ; Dumas ME; Rizkalla SW; Doré J; Cani PD; Clément K
    Gut; 2016 Mar; 65(3):426-36. PubMed ID: 26100928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma endocannabinoid levels in lean, overweight, and obese humans: relationships to intestinal permeability markers, inflammation, and incretin secretion.
    Little TJ; Cvijanovic N; DiPatrizio NV; Argueta DA; Rayner CK; Feinle-Bisset C; Young RL
    Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E489-E495. PubMed ID: 29438631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways.
    Montecucco F; Lenglet S; Quercioli A; Burger F; Thomas A; Lauer E; da Silva AR; Mach F; Vuilleumier N; Bobbioni-Harsch E; Golay A; Schindler TH; Pataky Z
    Thromb Haemost; 2015 Apr; 113(4):838-50. PubMed ID: 25413674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoids measurement in human saliva as potential biomarker of obesity.
    Matias I; Gatta-Cherifi B; Tabarin A; Clark S; Leste-Lasserre T; Marsicano G; Piazza PV; Cota D
    PLoS One; 2012; 7(7):e42399. PubMed ID: 22860123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation the effect of oleoylethanolamide supplementation on the abundance of Akkermansia muciniphila bacterium and the dietary intakes in people with obesity: A randomized clinical trial.
    Payahoo L; Khajebishak Y; Alivand MR; Soleimanzade H; Alipour S; Barzegari A; Ostadrahimi A
    Appetite; 2019 Oct; 141():104301. PubMed ID: 31132422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and chronic improvement in postprandial glucose metabolism by a diet resembling the traditional Mediterranean dietary pattern: Can SCFAs play a role?
    Vitale M; Giacco R; Laiola M; Della Pepa G; Luongo D; Mangione A; Salamone D; Vitaglione P; Ercolini D; Rivellese AA
    Clin Nutr; 2021 Feb; 40(2):428-437. PubMed ID: 32698959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-inflammatory effect of bacterial short chain fatty acids is partially mediated by endocannabinoids.
    Vijay A; Kouraki A; Gohir S; Turnbull J; Kelly A; Chapman V; Barrett DA; Bulsiewicz WJ; Valdes AM
    Gut Microbes; 2021; 13(1):1997559. PubMed ID: 34787065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat.
    Castonguay-Paradis S; Lacroix S; Rochefort G; Parent L; Perron J; Martin C; Lamarche B; Raymond F; Flamand N; Di Marzo V; Veilleux A
    Sci Rep; 2020 Sep; 10(1):15975. PubMed ID: 32994521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study.
    Depommier C; Everard A; Druart C; Plovier H; Van Hul M; Vieira-Silva S; Falony G; Raes J; Maiter D; Delzenne NM; de Barsy M; Loumaye A; Hermans MP; Thissen JP; de Vos WM; Cani PD
    Nat Med; 2019 Jul; 25(7):1096-1103. PubMed ID: 31263284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study.
    Abdulnour J; Yasari S; Rabasa-Lhoret R; Faraj M; Petrosino S; Piscitelli F; Prud' Homme D; Di Marzo V
    Obesity (Silver Spring); 2014 Jan; 22(1):211-6. PubMed ID: 23616305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole grain-rich diet reduces body weight and systemic low-grade inflammation without inducing major changes of the gut microbiome: a randomised cross-over trial.
    Roager HM; Vogt JK; Kristensen M; Hansen LBS; Ibrügger S; Mærkedahl RB; Bahl MI; Lind MV; Nielsen RL; Frøkiær H; Gøbel RJ; Landberg R; Ross AB; Brix S; Holck J; Meyer AS; Sparholt MH; Christensen AF; Carvalho V; Hartmann B; Holst JJ; Rumessen JJ; Linneberg A; Sicheritz-Pontén T; Dalgaard MD; Blennow A; Frandsen HL; Villas-Bôas S; Kristiansen K; Vestergaard H; Hansen T; Ekstrøm CT; Ritz C; Nielsen HB; Pedersen OB; Gupta R; Lauritzen L; Licht TR
    Gut; 2019 Jan; 68(1):83-93. PubMed ID: 29097438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a High-Protein Diet on Cardiometabolic Health, Vascular Function, and Endocannabinoids-A PREVIEW Study.
    Tischmann L; Drummen M; Joris PJ; Gatta-Cherifi B; Raben A; Fogelholm M; Matias I; Cota D; Mensink RP; Westerterp-Plantenga MS; Adam TC
    Nutrients; 2020 May; 12(5):. PubMed ID: 32455987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of the Building Research in CRC prevention (BRIDGE-CRC) trial: a 6-month, parallel group Mediterranean diet and weight loss randomized controlled lifestyle intervention targeting the bile acid-gut microbiome axis to reduce colorectal cancer risk among African American/Black adults with obesity.
    McLeod A; Wolf P; Chapkin RS; Davidson LA; Ivanov I; Berbaum M; Williams LR; Gaskins HR; Ridlon J; Sanchez-Flack J; Blumstein L; Schiffer L; Hamm A; Cares K; Antonic M; Bernabe BP; Fitzgibbon M; Tussing-Humphreys L
    Trials; 2023 Feb; 24(1):113. PubMed ID: 36793105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Endocannabinoids in Energy-Balance Regulation in Participants in the Postobese State-a PREVIEW Study.
    Drummen M; Tischmann L; Gatta-Cherifi B; Cota D; Matias I; Raben A; Adam T; Westerterp-Plantenga M
    J Clin Endocrinol Metab; 2020 Jul; 105(7):e2511-20. PubMed ID: 32333763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.